Sexual Health & Hormonal Peptides

Subcategories

This category is organized into two subcategories addressing distinct research domains within reproductive endocrinology and hormonal signaling investigation:

• Libido & Sexual Performance Peptides — compounds studied in melanocortin receptor binding assays, dopaminergic signaling pathway models, and in vitro neuroendocrine cascade research relevant to sexual behavior-associated receptor systems
• Fertility & Reproductive Hormone Peptides — compounds studied in GnRH receptor activation models, FSH and LH secretion marker profiling, and in vitro gonadotropin and steroidogenesis pathway research in pituitary and gonadal cell systems

Sexual Health & Hormonal Peptide Compounds: Research Catalog

PT-141 (Bremelanotide) — 10 mg

Kisspeptin-10 — 1 mg

GnRH (Gonadorelin) — 2 mg

hCG Beta Subunit Peptide — 1 mg

Research Applications: Four Areas of Laboratory Investigation

1. Melanocortin Receptor Binding and Neuroendocrine Signaling Research

PT-141 (Bremelanotide) is the primary melanocortin receptor research tool in this category. As a cyclic melanocortin analog derived from the MT-II sequence, it has been studied in published research for its selective binding affinity at MC3R and MC4R receptor subtypes expressed in hypothalamic neuronal cell models. Published assays have characterized its cAMP accumulation response in HEK293 cells transiently transfected with MC3R or MC4R constructs, its interaction with the dopaminergic system through D1 receptor co-expression models, and its downstream effects on oxytocin pathway gene expression in paraventricular nucleus-derived cell systems. These studies are conducted in vitro and do not constitute claims regarding sexual arousal or performance outcomes in subjects.

2. HPG Axis GnRH Pulse Regulation and Kisspeptin Signaling Models

The regulation of GnRH pulsatility through upstream kisspeptin signaling is a well-characterized research axis in reproductive neuroendocrinology. Kisspeptin-10 has been studied in published research for its KISS1R/GPR54 receptor binding dynamics, Gq-PLC-IP3 calcium signaling cascade activation, and downstream GnRH secretion marker profiling in GT1-7 hypothalamic neuron cell line models. GnRH itself serves as the downstream experimental ligand in pituitary gonadotroph cell assays using LβT2 and αT3-1 cell lines, with published studies characterizing GnRH receptor (GnRHR) internalization dynamics, ERK1/2 and c-Fos pathway activation, and LH beta-subunit mRNA expression profiling under defined pulse frequency and amplitude conditions.

3. Gonadotropin Receptor Interaction and Steroidogenesis Pathway Assays

LH receptor (LHCGR) interaction research using gonadotropin peptide fragments represents an established domain in reproductive endocrinology cell biology. Published studies using MA-10 Leydig cell and KGN granulosa cell line systems have characterized LH receptor binding competition dynamics, StAR protein expression as a steroidogenesis initiation marker, cAMP-PKA cascade activation profiling, and CYP11A1 and CYP17A1 enzyme activity assays as downstream steroidogenesis markers. hCG beta-subunit peptide fragments are used in competitive binding assays and receptor interaction models to characterize the determinant loop region contribution to LH receptor engagement under controlled in vitro conditions.

4. Gonadotropin Secretion Dynamics and Pituitary Cell Line Models

Pituitary gonadotroph cell line models — principally LβT2 and the alpha gonadotrope precursor line αT3-1 — represent the primary in vitro system for studying GnRH-stimulated LH and FSH secretion dynamics. Published assays in this domain use perifusion systems to study LH secretion pulse parameters under varying GnRH frequency and amplitude inputs, static incubation ELISA-based LH/FSH quantification, and transcriptomic profiling of LHb, FSHb, and CGA subunit gene expression in response to defined GnRH receptor activation patterns. These in vitro cell biology assays characterize gonadotropin secretion pathway dynamics at the molecular level without reference to fertility or reproductive outcomes in organisms.

Selecting the Right Compound for Your Research Protocol

Researchers designing studies in reproductive neuroendocrinology, gonadotropin signaling, or steroidogenesis pathway investigation typically evaluate compound selection based on receptor subtype specificity — particularly MC3R versus MC4R selectivity for melanocortin analogs and KISS1R versus GnRHR binding for HPG axis tools — the upstream versus downstream position of each compound within the HPG axis regulatory hierarchy, molecular stability in endocrine cell culture media including serum-containing formulations, and COA-verified purity with peptidase stability data where assay media contains serum-derived enzymes.

Novera provides complete product specifications for each compound including molecular weight, sequence, storage conditions, and available presentation formats. Researchers are encouraged to review compound data sheets and cross-reference with primary reproductive endocrinology literature before finalizing protocols. Novera does not provide experimental design guidance, dosing parameters, or outcome interpretation.

Institutional procurement offices and principal investigators with multi-compound or volume supply requirements are invited to contact Novera’s research supply team to confirm batch availability, lot consistency documentation, and GMP certification status for each referenced material.

Supply and Quality Standards

All compounds in this category are procured from USA-based GMP-certified manufacturing facilities. Standard quality documentation and protocols include:

• Certificate of Analysis (COA) for every batch confirming molecular identity and HPLC-verified purity
• Mass spectrometry confirmation of sequence and cyclization for cyclic peptides such as PT-141
• Fragment sequence and molecular weight documentation for hCG beta-subunit peptide lots
• Endotoxin testing (LAL method) available on request for all compounds
• Sterility certification for applicable lyophilized formulations
• Temperature-controlled cold-chain shipping for all stability-sensitive hormonal peptide materials
• Full compliance with USA regulatory frameworks governing research compound distribution

Novera does not supply compounds for human or veterinary administration. All purchase documentation classifies materials as research and laboratory use only. Institutional and bulk procurement arrangements are available subject to qualification review.

Sexual Health & Hormonal Peptides: Research Classification and Molecular Context

In reproductive endocrinology and neuroendocrine research literature, sexual health and hormonal peptides refer to amino acid sequences studied for their interactions with signaling pathways governing HPG axis regulation, gonadotropin secretion dynamics, steroidogenesis cascade activation, and melanocortin receptor-mediated neuroendocrine signaling. These compounds encompass synthetic receptor agonists and analogs such as PT-141, studied at MC3R/MC4R in hypothalamic models; RF-amide neuropeptides such as Kisspeptin-10, studied as KISS1R ligands and upstream GnRH pulse regulators; endogenous releasing hormones such as GnRH, studied in pituitary gonadotroph cell assays; and gonadotropin subunit fragments studied in LH receptor binding competition models.

Classification within this category is based on documented molecular interaction profiles in published reproductive biology and endocrinology literature. No compound is represented as a libido enhancer, sexual performance agent, hormone therapy, or fertility treatment of any kind. All materials are supplied as experimental research tools for mechanistic investigation in qualified laboratory settings by trained scientific personnel operating under appropriate institutional and ethical oversight frameworks.